Home Cart Sign in  
Chemical Structure| 1168091-68-6 Chemical Structure| 1168091-68-6

Structure of GDC-0623
CAS No.: 1168091-68-6

Chemical Structure| 1168091-68-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

GDC-0623 is a selective and ATP-uncompetitive MEK1 inhibitor with Ki value of 0.13 nM.

Synonyms: RG 7421; MEK inhibitor 1; GDC-0632

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of GDC-0623

CAS No. :1168091-68-6
Formula : C16H14FIN4O3
M.W : 456.21
SMILES Code : O=C(C1=C(NC2=CC=C(I)C=C2F)N3C(C=C1)=CN=C3)NOCCO
Synonyms :
RG 7421; MEK inhibitor 1; GDC-0632
MDL No. :MFCD25976760
InChI Key :RFWVETIZUQEJEF-UHFFFAOYSA-N
Pubchem ID :42642654

Safety of GDC-0623

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of GDC-0623

MAPK

Isoform Comparison

Biological Activity

Target
  • MEK1

    MEK1, IC50:0.13 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
H23 cells 1 μM 24 hours To study the effect of MAPK inhibitors on H23 cells, it was found that GDC-0623 did not significantly enhance HGF- and EGF-induced AKT phosphorylation. PMC5065770
A549 cells 1 μM 24 hours To study the effect of MEK inhibitors on KRAS-mutant lung cancer cells, it was found that MEK inhibitors including GDC-0623 enhanced HGF- and EGF-induced AKT phosphorylation. PMC5065770

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice Colon cancer model COLO 205 Oral 40 mg/kg/day Once daily for 14 days GDC-0623 showed similar activity to BI-847325 in the BRAF V600E-mutated colon cancer model COLO 205, with tumor regression during the treatment period. PMC10599287

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01106599 Solid Cancers PHASE1 COMPLETED 2025-08-14 Los Angeles, California, 90033... More >>, United States|Sacramento, California, 95817, United States|Oklahoma City, Oklahoma, 73104, United States|Nashville, Tennessee, 37203, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.19mL

0.44mL

0.22mL

10.96mL

2.19mL

1.10mL

21.92mL

4.38mL

2.19mL

References

 

Historical Records

Categories